Correlation of high post-treatment platelet reactivity assessed by light transmittance aggregometry and the VerifyNow P2Y₁₂ assay

By Kim In-Suk   Jeong Young-Hoon   Kang Min-Kyung   Koh Jin-Sin   Park Yongwhi   Hwang Seok-Jae   Kwak Choong   Hwang Jin-Yong   Kim Sunjoo  

Journal of Thrombosis and Thrombolysis, Vol. 30, Iss. 4, 2010-11 ,pp. : 486-495

Springer Publishing Company

Access to resources Recommend Favorite

Incomplete inhibition of platelet function as assessed by the platelet function analyzer (PFA-100) identifies a subset of cardiovascular patients with high residual platelet response while on aspirin

By Crescente M.   Mezzasoma A. M.   Del Pinto M.   Palmerini F.   Di Castelnuovo A.   Cerletti C.   De Gaetano G.   Gresele P.  

Platelets, Vol. 22, Iss. 3, 2011-05 ,pp. : 179-187

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of platelet function in aspirin treated patients with CAD

By Williams Marlene   Kickler Thomas   Vaidya Dhananjay   Ng’alla Ladina   Bush David  

Journal of Thrombosis and Thrombolysis, Vol. 21, Iss. 3, 2006-06 ,pp. : 241-247

Springer Publishing Company

Access to resources Recommend Favorite

VerifyNow and VASP phosphorylation assays give similar results for patients receiving clopidogrel, but they do not always correlate with platelet aggregation

By Bidet Audrey   Jais Catherine   Puymirat Etienne   Coste Pierre   Nurden Alan   Jakubowski Joseph   Nurden Paquita  

Platelets, Vol. 21, Iss. 2, 2010-09 ,pp. : 94-100

Informa Healthcare

Access to resources Recommend Favorite

Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel

By Mangiacapra Fabio  

Journal of Thrombosis and Thrombolysis, Vol. 32, Iss. 1, 2011-07 ,pp. : 54-58

Springer Publishing Company

Access to resources Recommend Favorite